Pharma sales in AMD markets to soar by 2026, says GlobalData

According to data and analytics company, GlobalData, pharmaceutical sales within the age-related macular degeneration (AMD) markets will soar to $11.5 billion by the year 2026. Read more

5 Apr 2018 14:53 Analysis